• Director, ACTG Immunology Speciality Laboratory (UNC) ACTG Executive Committee (2022-2024)

In the news

• 

  Supercharging T-Cells Against HIV’s Weak Spots: A New HIV Vaccine Study Reveals New Hope—and New Challenges—for Aging Patients

  T-cells are the immune system’s frontline defenders with a crucial role in controlling HIV. In a milestone clinical trial published in the Journal of Clinical Investigation, researchers with the UNC Institute for Global Health and Infectious Diseases (IGHID) at the UNC School of Medicine have demonstrated that new vaccines can significantly boost T cells targeting … Read more

• 

  IGHID Investigators Participate in CROI Conference

  Investigators with the Institute for Global Health and Infectious Diseases (IGHID) participated in the 2025 Conference on Retroviruses and Opportunistic Infections (CROI) in San Francisco, California, March 9-12. Following are some highlights.   In a CROI preview, Joe Eron, MD, was interviewed for the “Going Anti-Viral” IAS-USA podcast, discussing the state of HIV cure research … Read more

• 

  Nilu Goonetilleke Discusses Latest HIV Research During CROI 2025

  Nilu Goonetilleke, PhD, a member of the Institute for Global Health and Infectious Diseases and associate professor of medicine, was interviewed by Contagion Infectious Diseases Today during CROI, the Conference on Retroviruses and Opportunistic Infections. She discussed two studies that she led with first author Cindy Gay, MD, MPH. The interviews were posted on March 10. … Read more

• 

  IAMIGHID: Spotlighting the HIV Cure Team

  HIV/AIDS has been around for approximately 40 years, but many researchers say the end is in sight. The question is, will it be in our lifetime or just around the corner? This is a spotlight on the HIV CURE Center, comprising approximately 55 researchers and students, featuring David Margolis, MD, the director, Nancie Archin, PhD, a … Read more

Education